Cannapharmarx Inc (CPMD)
OTHER OTC:CPMD
US Market

Cannapharmarx (CPMD) Financial Statements

56 Followers

Cannapharmarx Financial Overview

Cannapharmarx's market cap is currently ―. The company's EPS TTM is $-0.024; its P/E ratio is -0.45; Cannapharmarx is scheduled to report earnings on August 19, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 25.84K----
Gross Profit$ -437.41K----
EBIT$ -11.14M$ 8.17M$ -209.51K$ -1.52M$ -953.23K
EBITDA$ -11.12M$ 8.08M$ -159.92K$ -1.52M$ -785.01K
Net Income Common Stockholders$ -11.72M$ 7.54M$ -564.37K$ -1.88M$ -1.41M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 12.09K$ 650.00$ 0.00$ 0.00$ 0.00
Total Assets$ 11.37M$ 11.75M$ 5.16M$ 5.32M$ 5.27M
Total Debt$ 7.56M$ 7.01M$ 10.77M$ 9.99M$ 9.07M
Net Debt$ 7.55M$ 7.01M$ 10.77M$ 9.99M$ 9.07M
Total Liabilities$ 34.90M$ 23.90M$ 25.79M$ 25.47M$ 23.48M
Stockholders Equity$ -23.53M$ -12.15M$ -20.63M$ -20.14M$ -18.21M
Cash Flow-
Free Cash Flow$ -548.83K$ -1.31M$ 119.70K$ -555.98K$ -612.63K
Operating Cash Flow$ -548.83K$ -1.30M$ 123.88K$ -482.17K$ -611.74K
Investing Cash Flow-$ -1.75K$ -4.18K$ -73.81K$ -893.00
Financing Cash Flow$ 560.27K$ 1.31M$ 92.69K$ 460.60K$ 493.31K
Currency in USD

Cannapharmarx Earnings and Revenue History

Cannapharmarx Debt to Assets

Cannapharmarx Cash Flow

Cannapharmarx Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis